Skip to content
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:
Switzerland
Share

Pharmaceutical Pipeline

  • Select programs in development, Phase 1 through Approval (removed after programs achieve approval in both US/EU)
  • Select Novel Therapy programs recently approved or with potential filings in the US/EU within a specified window as outlined in the Pharmaceutical Business Review.
  • Major US/EU Approvals and Submissions and Phase 2/3 Clinical Data presentations being planned or achieved for the year.
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue